The course of dyskinesia induction by different treatment schedules of levodopa in Parkinsonian rats: Is continuous dopaminergic stimulation necessary?-Reference-Cited by-同舟云学术

The course of dyskinesia induction by different treatment schedules of levodopa in Parkinsonian rats: Is continuous dopaminergic stimulation necessary?

Published:2008-04-28 Issue:7 Volume:23 Page:950-957
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Tsironis Christos,Marselos Marios,Evangelou Angelos,Konitsiotis Spiridon

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference19 articles.

1. Parkinson's disease;Lang;N Engl J Med,1998

2. Risk factors for motor response complications in L-dopa-treated parkinsonian patients;Peppe;Adv Neurol,1993

3. Striatal molecular mechanisms and motor dysfunction in Parkinson's disease;Chase;Adv Neurol,2001

4. Levodopa therapy: consequences of the nonphysiologic replacement of dopamine;Chase;Neurology,1998

5. Continuous dopaminergic stimulation in early and advanced Parkinson's disease;Stocchi;Neurology,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal genes in Parkinson model rats;Neuroscience Research;2017-09

2. Regenerative medicine for Parkinson’s disease using differentiated nerve cells derived from human buccal fat pad stem cells;Human Cell;2017-02-16

3. A community study outlines how to prevent Parkinson's disease motor complications in the clinic;European Journal of Neurology;2015-07-15

4. Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesias;Expert Review of Neurotherapeutics;2015-01-12

5. The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa;Brain;2014-07-17